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Summary
There is no doubt that the European Association for Cardio-Thoracic Surgery is a success story. In 2011, we celebrated the 25th anni-
versary of this professional organization. In 2012, we will celebrate the 25th anniversary of the European Journal of Cardio-Thoracic
Surgery. In addition, two other journals have been initiated, Interactive CardioVascular and Thoracic Surgery and the Multimedia
Manual of Cardio-Thoracic Surgery, and all of them can be accessed through CTSnet (www.ctsnet.org). The most recent development
was the birth of EACTS House, and it was to celebrate the ofﬁcial opening of EACTS House on 10 February 2011, that we held the
second Strategic meeting, ‘EACTS in the Future’. On this occasion, the EACTS council and delegates of the EACTS Domains (Domain of
Thoracic Disease, Domain of Vascular Disease, Domain of Congenital Cardiac Disease and Domain of Adult Cardiac Disease) came to-
gether with representative thoracic and cardio-vascular surgeons from North America, Asia and BRICS countries as well as senior man-
agers from industry in order to decide where to go from there. As a basis for starting the discussions, a sector analysis of the activities
of the Department of Cardio-Vascular Surgery at CHUV in Lausanne, Switzerland was performed in order to identify the trends in the
activities of our group of surgeons by pulling the consolidated data for the period running from 1 January 1995 to 31 December 2010.
Interestingly enough, the most frequent procedures like coronary artery bypass graft and valve repair/replacement did not increase
despite a growing programme. In our setting, the compensation came mainly from vascular surgery and mechanical circulatory
support. These data have to be put in perspective by the reports provided by the EACTS domain chairs in order to identify the chal-
lenges and opportunities for the future development of our specialties.
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EACTS IN THE PAST AND PRESENT
There is no doubt that the European Association for
Cardio-Thoracic Surgery is a success story. In 2011, we cele-
brated the 25th anniversary of this professional organization [1],
which counts now more than 2600 members, not only from
Europe, but from all over the world. In 2012, we will celebrate
the 25th anniversary of the European Journal of Cardio-Thoracic
Surgery (EJCTS) [2], which brings to its readers more than 2500
printed pages per year, has a print run of more than 5000 per
issue, and can of course be accessed through the world wide
web from practically anywhere at any time [3]. In addition, two
other journals have been initiated, Interactive CardioVascular
and Thoracic Surgery (ICVTS) [4, 5], and the Multimedia Manual
of Cardio-Thoracic Surgery (MMCTS) [6], and all of them can be
accessed through CTSNet (www.ctsnet.org).
The most recent development was the birth of EACTS House
(Fig. 1), and it was to celebrate the ofﬁcial opening of EACTS
House on 10 February 2011, that we held the second Strategic
meeting ‘EACTS in the Future’. On this occasion, the EACTS
council and delegates of the EACTS Domains (Domain of
Thoracic Disease, Domain of Vascular Disease, Domain of
Congenital Cardiac Disease and Domain of Adult Cardiac
Disease) came together with representative thoracic and cardio-
vascular surgeons from North America, Asia and BRICS countries
as well as senior managers from industry in order to decide
where to go from there or, in other words, to identify the chal-
lenges and opportunities for the future development of our
specialties.
In accordance with Winston Churchill’s saying ‘The farther back-
ward you can look the farther you are likely to see’ [7], a search of
the clinical database at the Department of Cardio-vascular
Surgery at CHUV in Lausanne, Switzerland was performed in
order to identify the trends in the activities of our group of sur-
geons by pulling the consolidated data for the period running
from 1 January 1995 to 31 December 2010. This cardiovascular
surgery department functions as a multisite organization operating
in six different hospitals as reported previously. Overall, the activ-
ities of our group of surgeons at the Department of
Cardio-Vascular Surgery, CHUV, Lausanne, Switzerland (current
staff surgeons of The Cardio-Vascular Surgery Group:
I. Bruschweiler, D. Delay, E. Ferrari, M. Hurni, B. Marty, P. Ruchat,
P. Tozzi, L.K. von Segesser) as documented by the number of
operations/procedures per year have been increasing (Fig. 2) from
1000 to more than 1600 over the study period.
However, the development of the number of procedures in
the main domains of activity has not been uniform over time. As
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a matter of fact, the operations for coronary artery bypass graft
(CABG) decreased several years ago (Fig. 3) and stabilized at a
level below the beginning of the observation period.
Interestingly enough, we have not seen a signiﬁcant increase in
the frequency of CABG (also for 2011) despite the recommenda-
tions by the recent EACTS–ESC guidelines on coronary artery
revascularization [8], which gave much more weight to surgical
revascularization in the decision-making process as compared
with the interventional procedures [8, Table 9], or the results of
the SYNTAX trial, which have been updated several times [9, 10].
This is in contrast to surgical units in other areas that report an
approximate 10% increase in surgical revascularizations since the
publication of the guidelines [8].
Operations for aortic valve disease have more than doubled
over the last 15 years (Fig. 4), peaking in the year 2009, and have
been decreasing since (conﬁrmed for 2011). This is despite the
fact that the implantation of catheter valves has been included
in this graph and that our group has been active in the experi-
mental setting since 2002 [11] and in the clinical setting since
2006 [12]. In contrast, the operations for mitral valve disease
(Fig. 5) increased substantially at the very beginning of the ob-
servation period but dropped off again at an early stage to that
which is seen for the aortic valve procedures. Whether this
Figure 1: EACTS House, Madeira Walk, Windsor, Berks, SL4 1EU, UK. The
EACTS House puts EACTS on the map and features an approximate 300 m2
for ofﬁces, meeting rooms, training facilities, etc.
Figure 2: The number of procedures performed per year by the
Cardio-Vascular Surgery Group has increased steadily.
Figure 4: The number of operations performed per year by the
Cardio-Vascular Surgery Group for aortic valve disease increased up to the
year 2009 but has decreased since, despite the inclusion of catheter valves in
this activity. Whether this observation is a temporary ﬂuctuation or the begin-
ning of a trend remains to be seen in the future.
Figure 3: The number of patients operated by the Cardio-Vascular Surgery
Group for coronary artery bypass graft (CABG) increased at the beginning of
the observation period, but has been on the decline ever since, even if it
appears to have stabilized.
Figure 5: The number of operations performed per year by the
Cardio-Vascular Surgery Group for mitral valve disease doubled at the very
beginning of the observation period, but numbers began to decrease at an
earlier timepoint than that observed with aortic valve operations i.e. prior to
2009. (see also Fig. 4).
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observation is due to the increased number of players in the
ﬁeld, introducing various types of percutaneous devices [13] or
whether the perception of the potential introduction of such
therapies can provide a sufﬁcient explanation remains to be
seen.
Another important part of our activities are the operations
performed for congenital heart disease (Fig. 6) in the paediatric
and the grown-up age groups. It was recognized quite some
time ago, that the improved outcome in paediatric congenital
heart surgery is a driver for surgery of congenital heart disease
in adults (grown-ups), the so-called GUCH-population [14], and
it can be shown here that the total number of patients operated
on for congenital heart disease in the paediatric and GUCH
groups has remained relatively stable overall.
Figure 7 displays the development of vascular operations in-
cluding operations on the ascending aorta, the aortic arch, the
descending thoracic and thoraco-abdominal aorta as well as the
supra-aortic arteries, visceral, renal and peripheral arteries. Some
of the increase demonstrated is due to endovascular aneurysm
repair for abdominal aortic aneurysms introduced in 1996 [15] as
well as thoracic endovascular aneurysm repair and its variations
[16]. However, there are also modiﬁcations in consolidation due
to changes in practice and/or the main location of the individual
surgeons of our group. Overall, the vascular operations and pro-
cedures represent a growing part of our activities and have been
a door opener for more complex catheter-based techniques like
transcatheter aortic valve implantation without angiography [17,
18].
Another area of growth in our ﬁeld appears to be terminal
heart failure. As a matter of fact, heart transplantation suffered
from low numbers mainly due to donor shortage for several
years, but recovered in 2010 and has been at similar levels since
(Fig. 8). In contrast, mechanical circulatory support with implan-
table devices [19] has steadily increased over the years, and even
more so has extracorporeal membrane oxygenation (ECMO), al-
though there are also indications for respiratory support [20]
included in this graph, because this service is provided by our
group.
Based on the numbers provided, we feel that there is increas-
ing competition in the treatment of traditionally surgical ﬁelds,
which include not only coronary artery disease, but also valvular
disease, congenital heart disease, aortic disease, arrhythmias (not
shown in detail here) and heart failure. For low numbers of
heart transplantation, it may be modern drug therapy and resyn-
chronization that delay the decision-making process in addition
to the lack of organ donors. However, the latter should not limit
the use of implantable assist devices that have become not only
more reliable and user friendly, but also smaller. In combination
with ECMO for the acute setting, there seems to be a real op-
portunity here for the future of our specialties. The following
manuscripts [21–24] will provide a detailed analysis of the chal-
lenges and opportunities of the four EACTS Domains, namely
the Domain of Thoracic Disease [21], the Domain of Vascular
Disease [22], the Domain of Congenital Cardiac Disease [23] and
the Domain of Adult Cardiac Disease [24].
Conﬂict of interest: Ludwig K. von Segesser is founder and
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